Clinical Trial Update: Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study evaluated PD-0360324 in combination with methotrexate in patients with rheumatoid arthritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• PD-0360324

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED